Latest News in the pharma Industry
Research & Development
Comparative analysis of a complex monoclonal antibody
24 May 2018
New poster describes how the EAF4 module enabled simultaneous measurement of size and surface charge characteristics of antibodies and proteins.
Read more
The shortest way from the lab to continuous production
24 May 2018
Bosch's new Xelum R&D for continuous production of oral solid dosage forms ensures a short time-to-market and optimum dosing of APIs.
Read more
Lilly expands oncology pipeline with acquisition
16 May 2018
Acquisition of AurKa Pharma expands Lilly's oncology pipeline with early-phase asset being studied in multiple tumour types.
Read more
Versatile lyophilizer for research, development or small-scale production
15 May 2018
Allows for easy and intuitive scale-up from research.
Read more
New online customer portal for custom research services
14 May 2018
Customers to gain a greater insight into their projects, better track project progress and improve communications.
Read more
Essential malaria parasite genes revealed
4 May 2018
NIAID-funded research could aid antimalarial drug development.
Read more
WuXi STA to build new R&D center in Shanghai
1 May 2018
Integrated one-site solution for partners to push forward innovative APIs and advanced intermediates from preclinical to commercial stage.
Read more
Cambrex completes new $3.2M analytical R&D laboratory at its High Point, NC Facility
24 Apr 2018
The aboratory’s primary function is to broaden analytical support for customer projects being developed and manufactured at the High Point site.
Read more
Manufacturing collaboration to advance PMD-026 toward IND
18 Apr 2018
MD-026 is the first RSK inhibitor to demonstrate potential disease-modifying properties in triple-negative breast cancer.
Read more
Omega-3s from fish oil supplements no better than placebo for dry eye
15 Apr 2018
NIH-funded study finds omega-3 fails to yield beneficial results in the clinic.
Read more.jpg)
Hope on the horizon for hair loss sufferers
13 Mar 2018
First patient treated in Follicum’s Phase IIa study of FOL-005 for stimulation of hair growth.
Read more
Biogen to acquire first-in-class Phase IIb ready asset for cognitive impairment
12 Mar 2018
PF-04958242 is an AMPA receptor potentiator designed to facilitate neurotransmission.
Read more